Skip to main content

Table 2 Risk stratification

From: Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial

 

Round 1

Round 2

p-value

All cases

 Control

37.1%

38.3%

0.778

 Int 1

38.7%

65.3%

< 0.001

 Int 2

41.9%

65.8%

< 0.001

 p-value

0.564

< 0.001

 

3+ CV risk factors

 Control

37.5%

28.8%

0.240

 Int 1

43.2%

60.8%

0.032

 Int 2

40.5%

59.5%

0.021

 p-value

0.768

< 0.001

 

2 CV risk factors

 Control

28.8%

46.3%

0.022

 Int 1

29.7%

70.3%

< 0.001

 Int 2

31.1%

71.6%

< 0.001

 p-value

0.951

0.001

 

Diabetic kidney disease

 Control

45.0%

40.0%

0.522

 Int 1

43.2%

64.9%

0.008

 Int 2

54.1%

66.2%

0.131

 p-value

0.366

0.001

 
  1. CV cardiovascular